ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 718165 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 718165; 2) Community: the network communities that were significantly associated with the response to NSC 718165; 3) Molecule: the relationships between components within communities and NSC 718165; 4) MDR: the compounds that were significantly associated with the NSC 718165.

NSC Compound Enrichment Correlation
NSC 743434 8-(4-{5-[3-(4-fluoro phenyl)-3-oxo-1-prophenyl]-2-methoxy phenoxy}pentoxy)-7-methoxy-2,3,5,11-a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a],[1,4]diazepin-5-one 0.0352383000003056 0.35576046
NSC 88915 Null 0.0352383000003056 0.30711375
NSC 95448 1H-1,2,4-Triazole, 3-(4-diazo-4H-imidazol-5-yl)- 0.0352383000003056 0.29906532
NSC 112758 Rubomycin 0.0352383000003058 0.042705651
NSC 122656 Null 0.0352383000003058 0.23857319
NSC 129518 Cyclopyrethrosin 0.0352383000003058 0.34443441
NSC 144310 4H-Thiopyran-4-one, 3,5-bis[(3,4-dimethoxyphenyl) methylene]-tetrahydro- 0.0352383000003058 0.38845763
NSC 17 4-AMINO-3-PENTADECYLPHENOL 0.0352383000003058 0.26924258
NSC 179940 Benzofurazan, 4-(4-methyl-1-piperazinyl)-7-nitro-, 3-oxide 0.0352383000003058 0.43435092
NSC 278619 L-Arabinose, 2-amino-4-[(2-amino-1-oxopropyl)amino]-2,4-dideoxy-, monohydrochloride 0.0352383000003058 -0.21796786
Total:68  Current:49    [First] [Prev] [Next] [Last]